Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni B Frisoni

Showing results (11-20 of 592) with videos related to

Pageof 60
Sort By:
The Lancet. Neurology|June 16, 2016
Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?Giovanni B Frisoni, Oskar Hansson
Expert Review of Medical Devices|September 16, 2009
Quantitative evaluation of Alzheimer's diseaseAnna Caroli, Giovanni B Frisoni
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 24, 2019
Brain imaging working group summaries for the European Joint Programme for Neurodegenerative Disease ResearchGiovanni B Frisoni, Jorge Jovicich
Mechanisms of Ageing and Development|November 11, 2005
Cognitive rehabilitation for severe dementia: critical observations for better use of existing knowledgeMarina Boccardi, Giovanni B Frisoni
Neurobiology of Aging|October 23, 2010
The specificity of amyloid imaging in the diagnosis of neurodegenerative diseasesGiovanni B Frisoni, Panteleimon Giannakopoulos
The Lancet. Neurology|January 22, 2022
From patients to disease: the difficult case of Alzheimer'sGiovanni B Frisoni, Aurelien Lathuilière
The Lancet. Neurology|January 22, 2013
Biomarkers for Alzheimer's: the sequel of an original modelGiovanni B Frisoni, Kaj Blennow
The Lancet. Neurology|July 24, 2021
Management of Alzheimer's disease takes a leap forwardGiovanni B Frisoni, Oskar Hansson
AJNR. American Journal of Neuroradiology|November 16, 2005
Multiple sclerosis and Alzheimer disease through the looking glass of MR imagingGiovanni B Frisoni, Massimo Filippi
The Lancet. Neurology|March 4, 2018
One step towards dementia preventionGiovanni B Frisoni, Frank Jessen
Pageof 60

Showing results (11-20 of 592) with videos related to

Sort By:
Pageof 60
The Lancet. Neurology|June 16, 2016
Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?Giovanni B Frisoni, Oskar Hansson
Expert Review of Medical Devices|September 16, 2009
Quantitative evaluation of Alzheimer's diseaseAnna Caroli, Giovanni B Frisoni
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 24, 2019
Brain imaging working group summaries for the European Joint Programme for Neurodegenerative Disease ResearchGiovanni B Frisoni, Jorge Jovicich
Mechanisms of Ageing and Development|November 11, 2005
Cognitive rehabilitation for severe dementia: critical observations for better use of existing knowledgeMarina Boccardi, Giovanni B Frisoni
Neurobiology of Aging|October 23, 2010
The specificity of amyloid imaging in the diagnosis of neurodegenerative diseasesGiovanni B Frisoni, Panteleimon Giannakopoulos
The Lancet. Neurology|January 22, 2022
From patients to disease: the difficult case of Alzheimer'sGiovanni B Frisoni, Aurelien Lathuilière
The Lancet. Neurology|January 22, 2013
Biomarkers for Alzheimer's: the sequel of an original modelGiovanni B Frisoni, Kaj Blennow
The Lancet. Neurology|July 24, 2021
Management of Alzheimer's disease takes a leap forwardGiovanni B Frisoni, Oskar Hansson
AJNR. American Journal of Neuroradiology|November 16, 2005
Multiple sclerosis and Alzheimer disease through the looking glass of MR imagingGiovanni B Frisoni, Massimo Filippi
The Lancet. Neurology|March 4, 2018
One step towards dementia preventionGiovanni B Frisoni, Frank Jessen
Pageof 60